These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3237706)

  • 41. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrahospital correlation of the international normalized ratio.
    Lazo-Langner A; Villa-Márquez R; Hernández-Hernández D; Rojas-Maya S; Piedras J
    Clin Appl Thromb Hemost; 2009; 15(2):220-4. PubMed ID: 18385150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term French experience in INR standardization by a procedure using plasma calibrants.
    Houbouyan LL; Goguel AF
    Am J Clin Pathol; 1997 Jul; 108(1):83-9. PubMed ID: 9208983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time.
    Roussi J; Drouet L; Samama M; Sié P
    Thromb Haemost; 1994 Nov; 72(5):698-704. PubMed ID: 7900077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
    Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
    Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Introduction of international normalized ratio of prothrombin time to evaluate multiple depletions of coagulation factors].
    Fujita S; Kagawa K; Fukutake K
    Rinsho Byori; 2002 Jun; 50(6):618-24. PubMed ID: 12166083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
    Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
    Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?
    Barcellona D; Fenu L; Cornacchini S; Marongiu F
    Thromb Res; 2009 Mar; 123(5):775-9. PubMed ID: 18814903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-center study of thromboplastin calibration precision--influence of reagent species, composition, and International Sensitivity Index (ISI).
    van den Besselaar AM; Bertina RM
    Thromb Haemost; 1993 Jan; 69(1):35-40. PubMed ID: 8446936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometer effects on the ISI of ECAA thromboplastins.
    Poller L; van den Besselaar AM; Jespersen J; Tripodi A; Houghton D
    Thromb Haemost; 1998 Oct; 80(4):615-23. PubMed ID: 9798981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardization of the INR: how good is your laboratory's INR and can it be improved?
    Favaloro EJ; Adcock DM
    Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].
    Renier JL; Baufine-Ducrocq H; Samama MM
    Ann Biol Clin (Paris); 1995; 53(6):353-6. PubMed ID: 8572381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.